Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
Quick Stats
Jul 02, 202660.0
AI Score
BUY0.91
Volume Ratio
Aug 05, 2026
Next Earnings
21
+ve Days (30d)
9
-ve Days (30d)
RCUS Stock Summary
Last updated Jul 02, 2026
RCUS is currently trading at $30.33, positioned above its 200-day moving average of $21.76, indicating a long-term uptrend. The stock has a 52-week range of $8.03 to $31.735.
Technical Analysis: The 50-day moving average stands at $25.4, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 65.763, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.213, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates RCUS at 60.0/100 with a BUY recommendation.
RCUS (Arcus Biosciences, Inc.) Indicators
Last updated Jul 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 65.763 |
| CMF (20) | 0.213 |
| ROC (10) | 25.746 |
| ADX (14) | 27.239 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 1.716 |
| AROONOSC (14) | 85.714 |
| WILLAMS %R (14) | -16.598 |
| MFI (14) | 91.519 |
RCUS Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
RCUS Price vs Max Options Open Interest
RCUS Max Change In Options Open Interest
RCUS Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Daily Out of Money Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Daily In the Money Options - Sort by Max open Interest (near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
RCUS Most Active Options by Volume(near term)
3rd July 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Arcus Biosciences, Inc. is above both 50 Day and 200 Day SMA which is considered Bullish.
RCUS Moving Averages Analysis
Arcus Biosciences, Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jul 02, 2026
Arcus Biosciences, Inc. has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Jul 02, 2026
RCUS (Arcus Biosciences, Inc.) Simple Moving Averages
Moving Averages are last updated Jul 02, 2026
| Days | MA |
|---|---|
| 10 | 29.09 |
| 20 | 26.34 |
| 30 | 25.66 |
| 50 | 25.4 |
| 100 | 23.59 |
| 200 | 21.76 |
RCUS Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 3.6 billion |
| Earnings/Share ($) | -3.17 |
| Net Proft Margin (%) | -1.5636 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -3.4829 |
| EPS Estimate Next Year ($) | -3.1029 |
| WallStreet Target Price ($) | 35.75 |
| Most Recent Quarter |